Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting.

This study was planned to assess the relationship of perioperative glycemic control to the subsequent risk of infectious complications and to compare early clinical outcomes of coronary artery bypass surgery in diabetics with nondiabetics in a single center. A total of 1090 adults who underwent coronary artery surgery in a five year period were included in a retrospective cohort study based on available chart review. Of 1090 patients, 400 had type II diabetes mellitus. Intraoperative and postoperative blood glucose levels in diabetic group were manipulated by means of a continuous insulin infusion. Data of pre- and postoperative blood glucose levels were evaluated with respect to postoperative infection risk for diabetics. Risks of early mortality, cerebrovascular accident, and postoperative infection in diabetic patients were compared with the nondiabetic group. High preoperative mean glucose levels were the main risk factor for the development of postoperative infection (p = 0.012 and p = 0.028 for the mean glucose levels 1 and 2 days before operation, respectively). For diabetic group, of 400 patients 20 (5%) were diagnosed to have postoperative infection (superficial sternal wound in 3 (0.75%), donor site infection in 4 (1%), mediastinitis in 5 (1.25%), urinary tract infection in 6 (1.5%), and lung infection in 2 (0.5%) patients). The diabetic group had significantly higher prevalence of mediastinitis, donor site infection, urinary tract infection and total infection (p values were 0.048, 0.013, 0.009, and 0.044, respectively). Early mortality was higher among diabetics than in nondiabetics (1.73% vs 3%, p = 0.048) but the risk of cerebrovascular accident in diabetics was not greater than in nondiabetics in early period. In patients with diabetes who undergo coronary artery bypass surgery, preoperative hyperglycemia is an independent predictor of short-term infectious complications and total length of stay in hospital.

[1]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[2]  W. Trick,et al.  Risk factors for radial artery harvest site infection following coronary artery bypass graft surgery. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  W. Trick,et al.  Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. , 2000, The Journal of thoracic and cardiovascular surgery.

[4]  J. Alpert,et al.  ACC/AHA guidelines for coronary artery bypass graft surgery , 1999 .

[5]  L. Norgren,et al.  Diabetes mellitus as a risk factor for early outcome after carotid endarterectomy--a population-based study. , 1999, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[6]  G. Grunkemeier,et al.  Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. , 1999, The Annals of thoracic surgery.

[7]  J. Hermans,et al.  Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. , 1998, Circulation.

[8]  T. Menges,et al.  Concentration of cefamandole in plasma and tissues of patients undergoing cardiac surgery: the influence of different cefamandole dosage. , 1997, Journal of cardiothoracic and vascular anesthesia.

[9]  G. Grunkemeier,et al.  Glucose control lowers the risk of wound infection in diabetics after open heart operations. , 1997, The Annals of thoracic surgery.

[10]  S. Nitter‐Hauge,et al.  Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. , 1996, Scandinavian journal of thoracic and cardiovascular surgery.

[11]  R. Jones,et al.  Mediastinitis After Coronary Artery Bypass Graft Surgery: Risk Factors and Long‐Term Survival , 1995, Circulation.

[12]  M. Mcmahon,et al.  Host defenses and susceptibility to infection in patients with diabetes mellitus. , 1995, Infectious disease clinics of North America.

[13]  M. Slaughter,et al.  A fifteen-year wound surveillance study after coronary artery bypass. , 1993, The Annals of thoracic surgery.

[14]  W. Bilker,et al.  Clinical trial of cefamandole, cefazolin, and cefuroxime for antibiotic prophylaxis in cardiac operations. , 1993, The Journal of thoracic and cardiovascular surgery.

[15]  G. Hicks,et al.  Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[16]  B. Kreter,et al.  Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. , 1992, The Journal of thoracic and cardiovascular surgery.

[17]  A. Galloway,et al.  Sternal wound infections and use of internal mammary artery grafts. , 1991, The Journal of thoracic and cardiovascular surgery.

[18]  R W Stewart,et al.  J. Maxwell Chamberlain memorial paper. Sternal wound complications after isolated coronary artery bypass grafting: early and late mortality, morbidity, and cost of care. , 1990, The Annals of thoracic surgery.

[19]  B. Polk,et al.  Risk factors for surgical-wound infection following cardiac surgery. , 1987, The Journal of infectious diseases.

[20]  V. Gott,et al.  Mediastinal infection after cardiac surgery. , 1984, The Annals of thoracic surgery.